Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.400
0.00 (0.00%)
Mar 9, 2026, 2:11 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 18.70M NOK in the half year ending June 30, 2025, a decrease of -2.02%. This brings the company's revenue in the last twelve months to 45.90M, up 43.97% year-over-year. In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M with 31.55% growth.
Revenue (ttm)
45.90M
Revenue Growth
+43.97%
P/S Ratio
2.00
Revenue / Employee
2.09M
Employees
22
Market Cap
91.65M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SoftOx Solutions AS | 13.59M |
| Aqua Bio Technology ASA | 101.51M |
| Zelluna ASA | 53.00K |
| Circio Holding ASA | 123.00K |
| Lytix Biopharma AS | 377.00K |
| Nykode Therapeutics AS | 4.57M |
| PCI Biotech Holding ASA | 4.69M |
| ArcticZymes Technologies ASA | 118.21M |